Voyageur Pharmaceuticals Ltd VYYRF

Primary Symbol: V.VM

Healthcare Drug Manufacturers - Specialty & Generic

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.

TSXV:VM - Post by User

Voyageur Pharmaceuticals Ltd > Something Fundamentally Wrong

<< Previous

Bullboard Posts

Next >>

Comment by whitenorth72on May 20, 2024 12:23pm

197 Views

Post# 36048765

RE:RE:RE:RE:RE:RE:RE:RE:Something Fundamentally Wrong

I understand the frustration with the process but I have been here for a while now and I understand the play here.
This company is going after a BIG player and strategic moves at this point are key. Hopefully the big picture begins to take shape and our investments take hold.

<< Previous

Bullboard Posts

Next >>

Nvidia reports record revenue in Q3